Koninklijke Philips (NYSE:PHG – Get Free Report) has received an average rating of “Hold” from the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and one has assigned a buy recommendation to the company.
PHG has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. UBS Group raised shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a report on Tuesday, April 30th. BNP Paribas cut shares of Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research note on Wednesday, February 7th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research note on Thursday, February 8th.
Check Out Our Latest Stock Report on Koninklijke Philips
Institutional Trading of Koninklijke Philips
Koninklijke Philips Price Performance
Shares of Koninklijke Philips stock opened at $26.82 on Tuesday. The company has a market capitalization of $24.91 billion, a price-to-earnings ratio of -27.94, a PEG ratio of 1.38 and a beta of 0.75. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. The stock’s 50-day simple moving average is $21.09 and its 200-day simple moving average is $21.18. Koninklijke Philips has a 52 week low of $17.75 and a 52 week high of $29.44.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 4/29 – 5/3
- What is the Australian Securities Exchange (ASX)
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Why Invest in 5G? How to Invest in 5G Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.